Literature DB >> 29947745

Maltreatment during childhood: a risk factor for the development of endometriosis?

C Liebermann1, A S Kohl Schwartz1,2, T Charpidou3, K Geraedts1, M Rauchfuss4, M Wölfler5, S von Orelli6, F Häberlin7, M Eberhard8, P Imesch9, B Imthurn1, B Leeners1.   

Abstract

STUDY QUESTION: Is maltreatment during childhood (MC), e.g. sexual abuse, physical abuse, emotional abuse and neglect, associated with diagnosis of endometriosis? SUMMARY ANSWER: Childhood sexual abuse, emotional abuse/neglect and inconsistency experiences were associated with the diagnosis of endometriosis while no such association was found for physical abuse/neglect and other forms of maltreatment. WHAT IS KNOWN ALREADY: Symptoms of endometriosis such as chronic pelvic pain, fatigue and depression, are correlated with MC, as are immune reactions linked to endometriosis. These factors support a case for a potential role of MC in the development of endometriosis. STUDY DESIGN, SIZE, DURATION: The study was designed as a multicentre retrospective case-control study. Women with a diagnosis of endometriosis were matched to control women from the same clinic/doctor's office with regard to age (±3 years) and ethnic background. A total of 421 matched pairs were included in the study. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Women with endometriosis and control women were recruited in university hospitals, district hospitals, and doctors' offices in Germany, Switzerland and Austria. A German-language version of the Childhood Trauma Questionnaire (CTQ) was used to evaluate MC. Diagnosis of endometriosis was confirmed histologically and classified according to ASRM criteria. MAIN RESULTS AND THE ROLE OF CHANCE: Women with endometriosis reported significantly more often than control women a history of sexual abuse (20%/14%, P = 0.0197), emotional abuse (44%/28%, P < 0.0001), emotional neglect (50%/42%, P = 0.0123) and inconsistency experiences (53%/41%, P = 0.0007). No statistically significant differences could be demonstrated for physical abuse/neglect (31%/26%, P = 0.1738). Combinations of different abuse/neglect experiences were described significantly more often in women with endometriosis. Frequencies of other MC, i.e. violence against the mother (8%/7%, P = 0.8222), drug abuse in the family (5%/3%, P = 0.0943), mentally handicapped family members (1%/1%, P = 0.7271), suicidal intentions in the family (6%/4%, P = 0.2879) and family members in prison (1%/1%, P = 0.1597) were not statistically different in women with endometriosis and control women. LIMITATIONS, REASONS FOR CAUTION: Some control women might present asymptomatic endometriosis, which would lead to underestimation of our findings. The exclusion of pregnant women may have biased the results. Statistical power for sub-analyses of physical abuse/neglect and sexual abuse was limited. WIDER IMPLICATIONS OF THE
FINDINGS: A link to MC needs to be considered in women with endometriosis. As there are effective strategies to avoid long-term consequences of MC, healthcare professionals should inquire about such experiences in order to be able to provide treatment for the consequences as early as possible. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: Endo_QoL NCT02511626.
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  childhood trauma questionnaire (CTQ); emotional abuse and neglect; endometriosis; maltreatment during childhood; physical abuse; sexual abuse

Mesh:

Year:  2018        PMID: 29947745     DOI: 10.1093/humrep/dey111

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Chronic Pelvic Pain in Endometriosis: Cross-Sectional Associations with Mental Disorders, Sexual Dysfunctions and Childhood Maltreatment.

Authors:  Johanna Netzl; Burkhard Gusy; Barbara Voigt; Jalid Sehouli; Sylvia Mechsner
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

2.  Satisfaction with medical support in women with endometriosis.

Authors:  Ilona Lukas; Alexandra Kohl-Schwartz; Kirsten Geraedts; Martina Rauchfuss; Monika M Wölfler; Felix Häberlin; Stephanie von Orelli; Markus Eberhard; Bruno Imthurn; Patrick Imesch; Brigitte Leeners
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

3.  Does endometriosis affect professional life? A matched case-control study in Switzerland, Germany and Austria.

Authors:  Marita Lina Sperschneider; Michael P Hengartner; Alexandra Kohl-Schwartz; Kirsten Geraedts; Martina Rauchfuss; Monika Martina Woelfler; Felix Haeberlin; Stephanie von Orelli; Markus Eberhard; Franziska Maurer; Bruno Imthurn; Patrick Imesch; Brigitte Leeners
Journal:  BMJ Open       Date:  2019-01-09       Impact factor: 2.692

Review 4.  Using Microbiome-Based Approaches to Deprogram Chronic Disorders and Extend the Healthspan following Adverse Childhood Experiences.

Authors:  Rodney R Dietert; Janice M Dietert
Journal:  Microorganisms       Date:  2022-01-21

5.  Living with endometriosis: Comorbid pain disorders, characteristics of pain and relevance for daily life.

Authors:  Janine Leuenberger; Alexandra Sabrina Kohl Schwartz; Kirsten Geraedts; Felix Haeberlin; Markus Eberhard; Stefanie von Orellie; Patrick Imesch; Brigitte Leeners
Journal:  Eur J Pain       Date:  2022-02-27       Impact factor: 3.651

Review 6.  The Role of Visceral Therapy in the Sexual Health of Women with Endometriosis during the COVID-19 Pandemic: A Literature Review.

Authors:  Tomasz Gozdziewicz; Grazyna Jarzabek-Bielecka; Dawid Luwanski; Malgorzata Wojcik; Katarzyna Plagens-Rotman; Malgorzata Mizgier; Magdalena Pisarska-Krawczyk; Witold Kedzia
Journal:  J Clin Med       Date:  2022-09-30       Impact factor: 4.964

Review 7.  Endometriosis and pain in the adolescent- striking early to limit suffering: A narrative review.

Authors:  Christine B Sieberg; Claire E Lunde; David Borsook
Journal:  Neurosci Biobehav Rev       Date:  2019-12-17       Impact factor: 8.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.